SCHEMBL4449

SCHEMBL4449

[C]1=NSC=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409006 0.61
SCHEMBL234916 0.58
SCHEMBL16534475 0.56
SCHEMBL876230 0.56
SCHEMBL30776105 0.56
Hydrochloric Acid SCHEMBL4754646 0.55
SCHEMBL94478 0.55
SCHEMBL4437233 0.50
SCHEMBL1042486 0.43
SCHEMBL11044374 0.43

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12198 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426182-B1 METHODS AND COMPOSITIONS FOR DENTAL TISSUE REPAIR AND/OR REGENERATION HARVARD COLLEGE (US) 2024-05-01 EP claimed
US-20240109866-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2024-04-04 US claimed
EP-3568390-B1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) 2024-03-06 EP claimed
US-11897898-B2 Pyridine macrocycle compounds as ASK1 inhibiting agents BIOGEN MA INC. (US) 2024-02-13 US claimed
WO-2024017315-A1 USE OF STEROID COMPOUND IN PREPARATION OF MEDICAMENT FOR PREVENTING AND/OR TREATING OPHTHALMIC DISEASES 广州润尔眼科生物科技有限公司 2024-01-25 WO claimed
CN-117186061-A 4-carbonylaminoisoindolin-1-one derivatives, compositions comprising the same, and methods of use 天津谷堆生物医药科技有限公司 2023-12-08 CN claimed
CN-117186062-A 4-carbonylaminoisoindoline-1, 3-dione compound, preparation method, pharmaceutical composition and application thereof 天津谷堆生物医药科技有限公司 2023-12-08 CN claimed
CN-117143082-A Azabicyclo [3.1.0] hexane derivatives useful as 3C-like protease inhibitors 广州国家实验室 2023-12-01 CN claimed
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2023-11-07 US claimed
WO-2023143452-A1 APPLICATION OF STEROIDAL COMPOUND IN PREVENTION AND/OR TREATMENT OF CATARACTS 广州润尔眼科生物科技有限公司 2023-08-03 WO claimed
EP-0739203-A1 METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF CELL THERAPEUTICS, INC. (US) 1996-10-30 EP claimed
EP-0728003-A1 METHOD FOR PREVENTING TISSUE INJURY FROM HYPOXIA CELL THERAPEUTICS, INC. (US) 1996-08-28 EP claimed
EP-0676958-A1 METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION CELL THERAPEUTICS, INC. (US) 1995-10-18 EP claimed
WO-1995025520-A1 THIOPROSTAGLANDINS AND -PROSTAGLANDIN-LIKE COMPOUNDS AND THERAPEUTIC USES THEREOF PHARMACIA AB (SE) 1995-09-28 WO claimed
WO-1995019171-A1 METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF CELL THERAPEUTICS, INC. (US) 1995-07-20 WO claimed
EP-0655062-A1 MORPHOLINO/THIOMORPHOLINO-TERMINATED ALKYLAMINO ETHYNYL ALANINE AMINO DIOL COMPOUNDS AS RENIN INHIBITORS. SEARLE & CO (US) 1995-05-31 EP claimed
WO-1995013808-A1 METHOD FOR SELECTIVELY INHIBITING IL-2 SIGNAL TRANSDUCTION CELL THERAPEUTICS, INC. (US) 1995-05-26 WO claimed
WO-1995013075-A1 METHOD FOR PREVENTING TISSUE INJURY FROM HYPOXIA CELL THERAPEUTICS, INC. (US) 1995-05-18 WO claimed
WO-1995012396-A1 METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION CELL THERAPEUTICS, INC. (US) 1995-05-11 WO claimed
WO-1994004518-A1 MORPHOLINO/THIOMORPHOLINO-TERMINATED ALKYLAMINO ETHYNYL ALANINE AMINO DIOL COMPOUNDS AS RENIN INHIBITORS G.D. SEARLE & CO. (US) 1994-03-03 WO claimed